These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 913717

  • 1. [Effects of an analogue of angiotensin II, [Sar1,Ile8] ATII, on blood pressure, plasma renin activity and plasma aldosterone in various forms of hypertension].
    Yamamoto I, Kim KS, Miyamori I, Morimoto S, Takeda R.
    Nihon Naibunpi Gakkai Zasshi; 1977 Jul 20; 53(7):910-20. PubMed ID: 913717
    [No Abstract] [Full Text] [Related]

  • 2. Effect of angiotensin II and of an angiotensin II analogue (Sar1-Ile8-angiotensin II) on blood pressure, plasma aldosterone and plasma renin activity in the dog.
    Beckerhoff R, Uhlschmid G, Vetter W, Armbruster H, Nussberger J, Reck G, Schmied U, Siegenthaler W.
    Clin Sci Mol Med Suppl; 1975 Jun 20; 2():41s-44s. PubMed ID: 1077788
    [Abstract] [Full Text] [Related]

  • 3. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T, Doi K, Ogihara T, Ichihara K, Hata T, Kumahara Y.
    Prog Biochem Pharmacol; 1976 Jun 20; 12():174-89. PubMed ID: 1019163
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of an angiotensin II analogue upon blood pressure, plasma renin concentration and plasma aldosterone in hypertensive patients.
    Vierhapper H, Waldhäusl W.
    Arzneimittelforschung; 1979 Jun 20; 29(8):1175-7. PubMed ID: 583019
    [Abstract] [Full Text] [Related]

  • 6. Effect of saralasin on plasma aldosterone in hypertensive man.
    Brown RD, Tucker R, Tue K, Wisgerhof M, Salassa R.
    J Lab Clin Med; 1978 Mar 20; 91(3):473-9. PubMed ID: 627750
    [No Abstract] [Full Text] [Related]

  • 7. Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension.
    Yamamoto Y.
    Jpn Heart J; 1975 Jul 20; 16(4):404-20. PubMed ID: 1152295
    [Abstract] [Full Text] [Related]

  • 8. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
    Beyer J, Liebau G, Steiner B, Schick K, Hayduk K.
    Verh Dtsch Ges Kreislaufforsch; 1977 Jul 20; 43():212-3. PubMed ID: 613577
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The influence of sar1 ala8 angiotensin II (saralasin) on plasma aldosterone in hypertensive patients.
    Donker AJ, van Hoogdalem P, Pratt JJ, Leenen FH.
    Acta Med Scand; 1979 Jul 20; 205(3):207-12. PubMed ID: 425848
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients].
    Higuma K, Fujishima S, Shionoiri H, Tochikubo O, Uneda S, Fujiki Y, Kaneko Y.
    Nihon Jinzo Gakkai Shi; 1984 Apr 20; 26(4):425-35. PubMed ID: 6381833
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
    Ogihara T, Hata T, Maruyama A, Nakamaru M, Mikami H, Kumahara Y.
    Endocrinol Jpn; 1979 Oct 20; 26(5):591-7. PubMed ID: 393505
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.
    Aust N Z J Med; 1976 Aug 20; 6(3 Suppl):48-52. PubMed ID: 1071403
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
    Fagard R, Lijnen P, Amery A, Reybrouck T.
    Contrib Nephrol; 1978 Aug 20; 11():175-8. PubMed ID: 699588
    [Abstract] [Full Text] [Related]

  • 19. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.
    Prog Biochem Pharmacol; 1976 Aug 20; 12():230-41. PubMed ID: 1019166
    [Abstract] [Full Text] [Related]

  • 20. A comparative study on (des-aspartyl1)-angiotensin II and angiotensin II in patients with essential hypertension.
    Mizuno K, Yamazaki M, Fukuchi S.
    Jpn Heart J; 1980 May 20; 21(3):357-65. PubMed ID: 6995642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.